Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Two cases of Stevens-Johnson syndrome following intake of klavox with review of literature.

Literature DB >> 18704477

Two cases of Stevens-Johnson syndrome following intake of klavox with review of literature.

Abstract

We present two case reports of Stevens-Johnson syndrome (triad of fever, stomatitis and conjunctivitis) due to klavox (amoxicillin + clavulanic acid) which has been reported in few publications as etiology but it is not commonly seen. We conclude that klavox can precipitate development of SJS.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2008 PMID： 18704477 DOI： 10.1007/s00405-008-0785-7

Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN： 0937-4477 Impact factor: 2.503

14 in total

1. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.

Authors: Christos S Zipitis; Nandu Thalange
Journal: Eur J Pediatr Date: 2006-09-29 Impact factor: 3.183

2. Erythema multiforme: report of two cases and speculation on immune mechanisms involved in the pathogenesis.

Authors: B Safai; R A Good; N K Day
Journal: Clin Immunol Immunopathol Date: 1977-05

3. Amoxicillin/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome.

Authors: D L Limauro; N H Chan-Tompkins; R W Carter; G J Brodmerkel; R M Agrawal
Journal: Ann Pharmacother Date: 1999-05 Impact factor: 3.154

Review 4. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.

Authors: Lars E French
Journal: Allergol Int Date: 2006-03 Impact factor: 5.836

5. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.

Authors: F Gaultier; A-L Ejeil; S Igondjo-Tchen; D Dohan; S M Dridi; L Maman; C B Wierzba; D Stania; B Pellat; A Lafont; G Godeau; B Gogly
Journal: Arch Dermatol Res Date: 2004-09-22 Impact factor: 3.017

6. Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS).

Authors: Nicola A Clayton; Peter J Kennedy
Journal: Dysphagia Date: 2007-02-08 Impact factor: 3.438

7. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.

Authors: Francesco Salvo; Giovanni Polimeni; Ugo Moretti; Anita Conforti; Roberto Leone; Olivia Leoni; Domenico Motola; Giulia Dusi; Achille Patrizio Caputi
Journal: J Antimicrob Chemother Date: 2007-04-21 Impact factor: 5.790

Two cases of Stevens-Johnson syndrome following intake of klavox with review of literature.

1. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.

2. Erythema multiforme: report of two cases and speculation on immune mechanisms involved in the pathogenesis.

3. Amoxicillin/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome.

Review 4. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.

5. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.

6. Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS).

7. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.

8. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Review 9. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes.

Review 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.

1. Amoxycillin and clavulanic acid induced Stevens-Johnson syndrome: A case report.

2. Co-amoxiclav-induced Stevens Johnson syndrome in a child.